About Us
Our Mission
Leadership
Board of Directors
Scientific Advisory Board
Technology
Cell Squeeze® Technology
Manufacturing
Pipeline
Pipeline
SQZ® eAPC Platform
SQZ® AAC PLATFORM
Patients
Investors
Overview
News
Events & Presentations
Publication, Presentations, & Posters
Stock Info
SEC Filings
Financials
Governance
Resources
Join Us
#HowCellsWork
About Us
Our Mission
Leadership
Board of Directors
Scientific Advisory Board
Technology
Cell Squeeze® Technology
Manufacturing
Pipeline
Pipeline
SQZ® eAPC Platform
SQZ® AAC PLATFORM
Patients
Investors
Overview
News
Events & Presentations
Publication, Presentations, & Posters
Stock Info
SEC Filings
Financials
Governance
Resources
Join Us
#HowCellsWork
Media
In The News
2020
SQZ Biotech to Present at November Virtual Investor Conferences
THE BIO REPORT
2020
Podcast: Squeezing New Possibilities into Cell Therapies
GEN: GENETIC ENGINEERING NEWS
2020
“Squeezing” Cells Could Transform Cell Therapy Manufacturing
BUSINESS INSIDER
2020
Meet the 21 biotech startups that top VCs say are poised to take off in the next 12 months
FORBES
2020
This MIT PhD Just Raised $65 Million For His Clinical Stage Cell Therapy Company
FIERCE BIOTECH
2020
SQZ Biotech snags $65M to push cancer vaccine, break into infectious disease
BOSTON BUSINESS JOURNAL
2020
A vaccine made at your bedside? A Boston-area startup thinks its possible
ENDPOINTS
2020
Bob Langer-founded cell therapy player loads up $65M to fund Roche-partnered cancer work while expanding into vaccines for infectious diseases
GEN: GENETIC ENGINEERING NEWS
2020
Cell-Based Immunotherapies Do Battle With Solid Tumors
BIOSPACE
2020
2020 Could be a Defining Year for SQZ Biotech
WUXI APPTEC
2019
SQZ Biotech’s Unique Technology Squeezes Cells to Transform Them into Therapeutics
PHARMAVOICE
2019
Creating a Culture of Innovation
PHARMAVOICE
2019
Inspiring the Next Generation
BIOPHARM INTERNATIONAL
2019
Science Focus Fuels Successful Process Development for Startups
LIFE SCIENCE LEADER
2019
Realizing Aspirations Through Entrepreneurship
S+P GLOBAL
2019
Drug companies chase deals for cell and gene therapies, biotech’s ‘next wave’
STAT NEWS
2018
SQZ Biotech pushes forward with its method to squeeze drugs into cells
ENDPOINTS NEWS
2018
SQZ play: Roche doubles down on a $1.37B-plus deal for a new approach to immuno-oncology out of Bob Langer’s lab
XCONOMY
2018
Roche and SQZ Biotech Expand R&D Pact in Pursuit of New Cancer Drugs
FIERCEBIOTECH
2018
Roche puts up $125M to expand SQZ cell therapy pact
BOSTON BUSINESS JOURNAL
2018
Boston’s SQZ signs cancer drug pact with Roche worth up to $1B
BIOWORLD
2018
PDQ for SQZ as Roche sweetens cell therapy partnership for potential $1.375B-plus
BIOCENTURY
2018
SQZ, Roche expand deal to jointly develop cancer cell therapies
FIERCEBIOTECH
2018
SQZ raises $72M as cell therapies close in on clinical trials
ENDPOINTS NEWS
2018
First-in-human studies in sight, SQZ’s cell therapy tech wins over a diverse group of investors in $72M round
XCONOMY
2018
SQZ Biotech Adds $72M as Cell Therapy Investment Keeps Burning Hot
BOSTON BUSINESS JOURNAL
2018
Cell therapy startup SQZ heads to clinical trials after $72M Series C round
BIOCENTURY
2018
SQZ raises $72M Series C
ENDPOINTS NEWS
2018
SQZ CEO featured in “The under-40s: How does the next generation of biopharma executives view the future?”
WORLD ECONOMIC FORUM
2017
How scientists are using engineered cells to defeat disease
BUSINESS INSIDER
2017
Meet the 30 biotech leaders under 40 who are searching for breakthrough treatments and shaping the future of medicine
XCONOMY
2017
Expanding Tissue and Squeezing Cells: Meet Xconomy’s Young Innovator Award Finalists
XCONOMY
2017
Xconomy Young Innovator Award Winner Armon Sharei—CEO Before 30
ROCHE CASE STUDY
2017
Fighting Cancer Using Novel Cell Engineering to Activate the Immune System
INC.
2017
SQZ Biotech CEO and Co-founder Named one of Inc.’s 30 Under 30 for 2016
A Hidden Start
2015
SCIENCE
MSEMPORDA
2015
Utility by Design – Bio-Engineered MedTech Devices
BOSTON MAGAZINE
2015
SQZ Biotech May Have Found a More Effective Method for Drug Delivery
BOSTINNO
2015
Where Are They Now: 4 Grads of Techstars Boston and MassChallenge
MIT SPECTRUM
2015
Giving Cells a Squeeze to Fight Disease
MIT ILP
2015
Putting the Squeeze on Cells
STEM CELL ASSAYS
2015
SQZ Biotech Named one of 10 Companies to Watch
MIT NEWS
2015
Freshly Squeezed Vaccines
THE BOSTON GLOBE
2015
Genetic Engineering on the Cheap: Implanting Genetic Material or Drugs may get a whole lot Simpler
XCONOMY
2015
With SQZ Deal, Roche Finally Dips Its Toes into Cell Therapy
FORBES
2015
Armon Sharei named in 2015 30 Under 30 in Healthcare
FIERCE BIOTECH
2015
SQZ Biotech Name in Fierce 15 2015
STAT
2015
SQZ’s Amy Schulman named one of three to Watch in Kendall Square in 2016
WHAT'S "IN" INNOVATION
2015
Head of J&J Innovation names SQZ one of 2015’s “Thrilling Three”
BOSTON BUSINESS JOURNAL
2015
Boston Biotech Startup SQZ Seals a $500M Deal with Drug Giant Roche
MEDCITY NEWS
2014
SQZBiotech’s Cell-Squeezing Could be a Better way to Reprogram Cells
THE SCIENTIST
2014
Entry Requirements: Recent Developments in Cell Transfection and Molecular Delivery Technologies
SQZ Biotech
2014
LABIOTECH TOUR
THE BOSTON GLOBE
2014
Mass. Life Science Firms Offered a Ticket to Space Station Read More
MEDCITY NEWS
2014
SQZBiotech’s “Cell-Squeezing” Wins Top Accolades at MassChallenge, Headed to Outer Space